Home > Healthcare > Drug Device Combination > Therapeutic Systems > Oncology Market

Oncology Market Share

Report ID: GMI4879
Published Date: Apr 2023
Report Format: PDF

Download Free Sample

Oncology Market Share

F. Hoffmann-La Roche
Merck & Co Inc
Abbott
Pfizer
Bayer AG
AbbVie Inc
Thermo Fischer Scientific
Kite Pharma (Gilead Science, Inc)
GE Healthcare
Siemens Healthineers AG
Amgen Inc
Biocartis
BioMerieux SA
Janssen Diagnostics LLC (Johnson & Johnson)
Astellas Pharma Inc
AstraZeneca
Bio-Rad Laboratories Inc
Sysmex Corporation,
Tesaro Inc (GlaxoSmithKline Plc)

are some of the major market participants worldwide.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

The global market for oncology reached over USD 280 billion in 2022 and is anticipated to exhibit 9.7% CAGR from 2023-2032 due to increasing government support.

Hospitals will record over USD 462 billion by 2032 owing to the strong presence of highly trained professionals in these settings for handling advanced cancer diagnosis equipment.

North America held 46% of the oncology market share in 2022 on account of rising burden of cancer in the U.S.

GE Healthcare, F. Hoffmann-La Roche, Pfizer, Bayer AG, Merck & Co., Inc., Abbott, AbbVie Inc., Thermo Fischer Scientific, Siemens Healthineers AG, Amgen Inc., Astellas Pharma, Inc., and AstraZeneca are a few major oncology industry players.